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Abstract
Cytolytic T lymphocytes kill target cells by two independent cytolytic mechanisms. One pathway
depends on the polarized secretion of granule-stored proteins including perforin and granzymes,
causing target cell death through membrane and DNA damage. The second cytolytic effector
system relies on the interaction of the Fas ligand (FasL) on the effector cell with its receptor (Fas)
on the target cell, leading to apoptotic cell death. Using mixed lymphocyte culture (MLC)-derived
primary T lymphocytes of perforin-knockout and gld (with non-functional FasL) mice, the molecular
basis of the two killing mechanisms was compared. The activity of both pathways was dependent
on extracellular Ca2+. Incubation of MLC-stimulated primary T cells with protein synthesis
inhibitors prior to TCR triggering impaired FasL cell surface expression and abolished cytolytic
activity, although the cells exhibited an intracellular pool of FasL. The perforin-dependent
mechanism induced cell death more rapidly, although both pathways ultimately showed similar
killing efficiencies. Both pathways induced comparable levels of DNA degradation, but Fas-induced
membrane damage was less pronounced. We conclude that upon TCR triggering FasL may be
recruited in part from pre-existing intracellular stores. However, efficient induction of target cell
death still depends on the continuous biosynthesis of FasL molecules.
Introduction
Cytotoxic T lymphocytes (CTL) play a crucial role in the
clearance of viral infections, tumor protection and graft rejec-
tion. Recently, the use of knockout mice has demonstrated
the presence of two independent cytotoxic pathways in CTL
(1,2). One mechanism consists of the directional release of
cytotoxic granule-stored effector molecules upon specific
interaction with a target cell, eventually leading to cell lysis
and apoptosis (3). Perforin, a granule protein capable of
forming transmembrane pores in a Ca2+-dependent manner,
is responsible for membrane damage (4,5), but fails to induce
nuclear damage (6). Apoptosis is brought about by granzyme
A or B, two granule proteins which belong to the family of
serine proteases (7-10).
A second cytotoxic mechanism used by CTL depends on
the interaction of the Fas ligand (FasL) and its cognate
receptor (11). Fas-based killing can function in the absence
of extracellular Ca2+ (11) and represents the major killing
pathway of CD4+ CTL (12,13). FasL is a 40 kDa class II
transmembrane protein belonging to the tumor necrosis factor
family, and is expressed in a variety of different tissues
particularly spleen, thymus, testis, kidney and lung (14). In
addition to its role in CTL-mediated cytotoxicity, Fas is implic-
ated in immune homeostasis as evidenced by the analysis of
mutant mouse strains for FasL (gld) and Fas (Ipr) (15). With
age, these mice accumulate a large amount of non-malignant
CD4~CD8~ T cells in their spleen and lymph nodes, and
develop autoimmune disease pathology similar to systemic
lupus erythematosus. Various studies examining the steps of
T cell development regulated by the Fas/Apo-1 system have
suggested that Fas is involved in the clonal deletion of
lymphocytes in the periphery (16,17).
In the present study, we compared the mechanisms of
perforin- and Fas-mediated killing. In our experimental system,
Fas- and perforin-dependent pathways induced rapid cell
death via apoptosis. Although FasL could be detected inside
the CTL before TCR engagement, killing was dependent on
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de novo protein synthesis, suggesting either the need for
continuous ligand synthesis or the production of a putative
FasL-activating protein
Methods
Cell lines and mice
A murine B lymphoma cell line, A20 (H-2d, ATCC TIB 208), a
murine fibrosarcoma clone, WEHI-164 clone 13 (H-2d' ATCC
CRL 1751), and an embryonic fibroblast cell line, 3T3.A31
(H-2d, ATCC CRL 6588), were maintained in DMEM (Gibco,
Basel, Switzerland) supplemented with 5% FCS, 10 mM
HEPES (pH 7.4) and 5x10~5 M |}-mercaptoethanol To gener-
ate concanavalin A (Con A) blasts, spleen cells from DBA/2
mice (H-2d) were freed from red blood cells and activated in
complete DMEM supplemented with Con A (4 |ig/ml, Sigma)
for 3 days. Alloreactive CTL were generated in a 5 day
mixed lymphocyte culture (MLC) as previously described
(18). Responder spleen cells (2 5xi06/ml) were obtained
from adult (5- to 6-week-old) homozygous perfonn-deficient
mice (19) and C57/B6 gld mice (H-2b; Jackson Laboratory,
Bar Harbor, ME). Stimulator cells were irradiated spleen cells
(2.5x106/ml, 3000 rad; 1 rad = 0 01 Gy) from DBA/2 mice
(Iffacredo, Grenoble, France). All cells were cultured in a
humid atmosphere containing 5% CO2 at 3°C.
Cytotoxicity assay for MLC
Cytotoxicity assays were performed as previously described
(20) To measure membrane damage, A20 cells or Con A
blasts (106 cells in DMEM with 5% FCS) were labeled with
100 p.Ci [51Cr]sodium chromate (Amersham, Zurich, Switzer-
land) for 1 h in a final volume of 200 |xl. For DNA degradation,
target cells (2X106) were labeled overnight with 2.5-5 nCi
[3H]thymidine (Amersham). 3T3.A31 fibroblasts and WEHI-
164 fibrosarcoma cells were labeled with [51Cr]sodium chro-
mate (2 (iCi/well) in 96-well plates for 12-16 h (21). Cytotoxicity
was measured in a 7 h assay. For the inhibitor studies,
MLC were preincubated with the various metabolic inhibitors
(actinomycin D 2.5 ng/ml; cycloheximide 2.5 ng/ml; emetine
5 ng/ml) for 45 min and either washed or directly mixed with
labeled target cells. All inhibitors were obtained from Sigma
(Buchs, Switzerland). In order to preactivate CTL, cells were
incubated for 3 h in a mixture of phorbol 12-myristate 13-
acetate (PMA; Sigma; final concentration of 5 ng/ml) and
ionomycin (Sigma; 0.5 ng/ml final).
Flow cytometnc analysis
Primary MLC were taken at day 6 of stimulation and were
centrifuged for 20 min at 2000 r.p.m. over a Ficoll-Hypaque
cushion (Pharmacia, Location?) to eliminate dead cells.
Washed buffy coat cells were stained with affinity-purified
polyclonal antibodies against the FasL (PE62; M. Hahne etal,
submitted for publication) followed by a fluorescein-coupled
donkey anti-rabbit IgG antibody (Dianova, Hamburg,
Germany) The samples were analyzed on a FACScan cyto-
meter (Becton Dickinson, Mountain View, CA).
Immunofluorescence microscopy and Western blot analysis
Primary MLC at day 6 of stimulation were enriched for T cells
by depletion of B220+ cells on a FACS cell sorter Remaining
cells were cultured for 4 h in either the presence or absence
of PMA (0.5 ng/ml) and ionomycin (0.5 ng/ml) Subsequently,
cells were washed with PBS and plated onto glass slides
(pretreated with polylysine at 50 ng/ml for 30 min) Cells were
fixed and permeabilized in methanol at -20°C for 5 mm.
Slides were then incubated with the polyclonal antibody anti-
PE62 (MAP-RGQSCNNQPLNHKVYMRNSKYPEDL), affinity-
purified against the FasL peptide PE82 (GQSCNNQPL-
NHKVYMRNSKYPEDK). As a specificity control, the specific
peptide PE82 (100 ng/ml) or an unrelated peptide PE58
(EDEMPKTLYVGNLS) were added during the first antibody
incubation. Bound antibody was visualized with a donkey
anti-rabbit FITC-conjugated secondary antibody (Dianova).
Confocal microscopy was performed using the Zeiss LSM
confocal laser system. Specimens were observed under
epifluorescence illumination with a 488 nm scanning argon
beam. For Western blotting, 2X106 sorted T lymphocytes
were lysed in 50 nl of cell lysis buffer (0.5% Triton X-100, 300
mM NaCI in 50 mM Tris-HCI, pH 7.6) containing 1 mM
phenylmethylsulfonyl fluoride The postnuclear fraction was
separated on a 10% SDS-PAGE and transferred to nitrocellu-
lose FasL was detected with the polyclonal antibody anti-
PE62 (10 n9/m|) anc l secondary anti-rabbit IgG antibody
coupled to horseradish peroxidase (Sigma). Specificity con-
trols were performed by adding either the specific peptide
(PE82, 100 ng/ml) or an unrelated peptide (PE58, 100 ng/ml)
during the first antibody incubation. Blots were developed
using the Enhanced Chemiluminescence kit from Amersham
Results
Fas-mediated cytotoxicity is dependent on extracellular
calcium
Perforin-mediated cytotoxicity is strictly dependent on extra-
cellular calcium, which is required for TCR-regulated granule
exocytosis as well as the lytic activity of perforin itself (22). In
contrast, Fas-based cytotoxicity of T cell clones has been
reported to work in the absence of Ca2+ (1,10,17,23). In
primary T cells, however, depletion of extracellular calcium
with Mg2+-EGTA (3 mM/5 mM) abolished perforin- as well as
Fas-mediated killing (Fig. 1). Fas-mediated cytotoxicity in
primary MLC is specific and dependent on TCR engagement
(1). To investigate if inhibition of TCR signaling, a calcium-
dependent event, was responsible for the abrogation of Fas-
mediated cytotoxicity, we preincubated effector cells for 3 h
with PMA plus ionomycin. These stimuli have been widely
used to up-regulate FasL surface expression (14). In contrast
to the perforin-mediated killing activity, Fas-mediated killing
was partially restored by this treatment, suggesting that
calcium is needed for the TCR signal-induced surface expres-
sion of FasL, but not for the interaction of the ligand with its
receptor.
The Fas-based pathway kills targets with a lag period
Perform-dependent killing is a rapid event due to the produc-
tion and storage of readily accessible cytotoxic effector
molecules prior to target cell contact. In order to compare
the kinetics of perforin- and Fas-dependent killing pathways,
target cells were incubated with g/d-derived or perforin-
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Fig. 1. EGTA inhibits Fas- and perforin-mediated cytotoxicity. The
cytotoxic activity of MLC (5 days after stimulation) derived from
perforin-deficient and g/dmice was assessed in a standard 4 h 51Cr-
release assay against A20 target cells in the absence (squares)
or presence (diamonds) of Mg2+-EGTA. Effector cells were also
preactivated for 3 h with PMA plus ionomycm and then assayed for
their cytolytic activity (circles). E, effector, T, target.
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Fig. 2. Fas-mediated killing shows slower kinetics, but similar
efficiency as the perforin-mediated pathway. (A) The cytotoxic activity
of MLC derived from perforin-deficient (squares) and gld mice
(circles) was measured in a standard 4 h 51Cr- and [3H]thymidine-
release assay against A20 cells (open symbols) and Con A blasts
(filled symbols). Radioactivity released into the supernatant was
measured at the indicated time points. (B) As in (A), but either WEHI-
164 fibrosarcoma cells (filled symbols) or 3T3.A31 fibroblasts (open
symbols) were used as target cells 51Cr release was measured at
indicated time points up to 8 h
deficient CTL at a 30:1 effectontarget cell ratio (Fig. 2). At
the indicated time points, membrane and DNA damage was
measured. Hematopoietic target cells, i.e. A20 B lymphomas
and Con A blasts, were rapidly killed via the perforin-mediated
pathway, leading to significant membrane and DNA damage
within the first 2 h (Fig. 2A). In contrast, killing by Fas showed
a lag period of up to 2 h during which only a minor fraction
of targets were killed. In particular, membrane damage was
significantly delayed Even at the endpoint of the assay (4 h),
where both mechanisms showed comparable efficiency in
DNA fragmentation, Fas-induced membrane damage was still
inferior to perforin-mediated cytolysis (30-50% of reduction).
Similar results were obtained when fibroblast lines were
used as target cells (Fig. 2B). Again, the perforin-dependent
pathway induced cell death more rapidly, although differences
in membrane damage were less pronounced for 3T3.A31
target cells.
Fas-mediated cytotoxicity requires de novo RNA and protein
synthesis
Perforin-mediated cytotoxicity is independent of de novo RNA
and protein synthesis, since preformed cytotoxic effector
molecules are already stored in cytoplasmic granules of
activated T cells. To analyze the requirement for an intact
metabolic machinery during Fas-mediated killing, cytotoxicity
tests with A20 cells as targets were performed in the presence
of either actinomycin D, an RNA synthesis inhibitor, or the
two protein synthesis inhibitors cycloheximide and emetine.
While perforin-mediated cytotoxicity was only slightly inhibited
by either of the treatments (Fig. 3A), complete inhibition of
Fas-mediated killing was observed, suggesting that both de
novo RNA and protein synthesis is a prerequisite for this lytic
activity. To demonstrate that the added inhibitors act on the
effector and not on the target cells, perforin-deficient CTL
were pretreated with either actinomycin D or emetine for 1 h
and washed three times before testing their cytolytic activity.
As shown in Fig. 3(B), the results were essentially the same
as before, pinpointing the effect of the metabolic inhibitors to
the effector cells.
Treatment of T lymphocytes with PMA plus ionomycin has
been shown to increase FasL-specific mRNA and to up-
regulate cell surface expression (14). Effector cells were
incubated with these stimuli prior to the cytotoxicity test to
investigate if such a pre-activation step could substitute for
the need of de novo RNA and protein synthesis. After 3 h of
incubation with PMA plus ionomycin, metabolic inhibitors were
added and cytotoxic activity was determined. Killing activity
of g/d-derived CTL remained unchanged (Fig. 3C). In contrast,
the actinomycin D-induced inhibition of Fas-mediated killing
was rescued by the prior PMA plus ionomycin treatment.
Continuous de novo protein synthesis, however, was still
needed for efficient killing.
The critical requirement for ongoing protein synthesis during
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Fig. 3. Fas- and perforin-mediated killing can be discriminated by
metabolic inhibitors The cytotoxic activity of MLC derived from
perform-deficient and g/dmice was assessed in a standard 4 h 51Cr-
release assay against A20 target cells in the absence (squares) or
presence of actinomycm D (diamonds), cycloheximide (circles) and
emetine (triangles) In (A), metabolic inhibitors were included during
the whole assay. In (B), only effector cells were pretreated with the
inhibitors for 1 h prior to the assay. In (C), effector cells were
preactivated with PMA plus lonomycin for 3 h Subsequently, the
inhibitors were added and cytotoxicity assays were performed after
1 h of incubation E, effector, T, target
Fig. 4. Efficient FasL surface expression requires protein synthesis
MLC-denved lymphocytes were stained with an affinity-purified
polyclonal antibody anti-FasL (anti-PE62) followed by donkey anti-
rabbit coupled to FITC and analyzed by flow cytometry Cells were
analyzed after 4 h of incubation in the absence or presence of PMA
plus lonomycin In the last panel, cells were preincubated with
cycloheximide for 1 h prior to activation. An isotype control was
included
need a second signal through TCR cross-linking. Our FACS
experiments neglect a possible influence of Fas binding on
FasL surface expression. Indeed, it has been shown for
CD40L that interaction with its receptor leads to down-
modulation of the complex. Thus, the half-life of FasL on a T
lymphocyte may be even shorter in a 'CTL-target cell' than
in a 'CTL only' system, explaining the dramatic effect of
protein synthesis inhibitors on Fas-mediated cytotoxicity.
FasL-based killing was investigated in more detail. Although
the direct interference of the protein synthesis inhibitors with
FasL synthesis and surface expression remained the most
likely explanation, other reasons such as reduced expression
of adhesion molecules could not be excluded. Non-activated,
activated or cycloheximide-treated, activated CTL were there-
fore analyzed by FACS for the presence of surface FasL. With
reference on the isotype control, only a minority of non-
activated cells (4.3%) specifically expressed FasL on their
surface, whereas PMA plus ionomycin treatment up-regulated
FasL surface expression in a distinct subpopulation (12.1%)
(Fig. 4). Pretreatment of MLC with cycloheximide prior to
activation reduced FasL expression to base levels (5 4%),
suggesting that this FasL down-regulation may be responsible
for the observed inhibition of cytotoxic activity. Similar results
were obtained when cells were pretreated with emetine (data
not shown). These findings are in agreement with earlier data
(23), which showed that primary MLC-derived T lymphocytes,
although they weakly express FasL on their cell surface (Fig.
4), are not capable to kill Fas-positive bystander cells, but
Primary MLC-derived T cells express intracellular FasL
In order to determine if the observed activation-induced
surface expression is due to de novo synthesis of the ligand
or rather due to translocation of the protein from an intracellular
pool to the cell membrane, MLC enriched for T lymphocytes
(B220~) were either analyzed by Western blotting or immuno-
fluorescence microscopy using FasL-specific antibodies. Sur-
prisingly, both methods revealed the presence of FasL already
in MLC-derived T cells prior to TCR triggering. In Western
blot analysis, a specific band with an apparent mol. wt of 40
kDa was detected, which could be competed with the specific
(PE82, 100 ng/ml), but not with an unrelated peptide (PE58,
100 ng/ml) (Fig. 5) PMA plus ionomycin activation did not
significantly change the level of FasL expression. However,
caution must be taken in the interpretation of this experiment,
since we observed considerable cell loss during the activation
period. It may well be that activation leads to the induction of
T cell suicide by the Fas pathway (2) and subsequently to
the loss of FasL expressing cells. To localize FasL inside the
cell, we performed immuno-staining of permeabilized non-
Comparison of Fas- and perforin-mediated cytotoxicity 61
C/5
anti-PE62
- - - - + + + PMA/Ionomycin
. . + . . + . PE82
- - - + - - + PE58
kDa
mm - — FasL
Fig. 5. MLC-stimulated T lymphocytes express FasL. Sorted MLC-
derived T lymphocytes, cultured for 4 h in the absence or the
presence of PMA plus lonomycin, were lysed and separated on a
10% SDS-PAGE under non-reducing conditions Western blot analysis
was performed using the affinity-purified polyclonal antibody anti-
FasL (anti-PE62). As control, the non-immune serum (NIS) was
included To demonstrate the specificity of the anti-PE62 antibody,
competition experiments were performed in the presence of either
the specific (PE82; 100 ng/ml) or a non-specific peptide (PE58, 100
ng/ml) Note the presence of cross-reactive high molecular species,
demonstrating equal loading
activated T cells (Fig. 6A and D). The affinity-purified poly-
clonal antibody anti-PE62 demonstrated the presence of FasL
within the cytoplasm as a distinct staining underneath the
plasma membrane, which could be competed with the specific
peptide PE82 (100 ng/ml) (Fig. 6 B). Unfortunately, the sharp-
ness of the staining was never high enough to detect any
defined structure. In summary, our findings suggest that T
cells accumulate intracellular FasL already upon allogeneic
stimulation, but that the majority of the protein is only
expressed on the cell surface upon a second TCR
engagement.
Discussion
T cell-mediated cytotoxicity plays an important role in cellular
immunity. Recently, two mechanisms have been shown to
account for the main cytotoxic activity of in vitro and in vivo
generated CTL and certain T cell lines (1,24-26). The 'clas-
sical' granule exocytosis pathway, strictly dependent on per-
forin, has been identified as one of the cytotoxic mechanisms.
In vivo studies in perforin-deficient mice clearly showed that
perforin-mediated cytotoxicity plays a major protective role in
viral infections, immunity against bacteria (Listeria) and tumor
rejection (2,26,27).
A second pathway involves the Fas/Apo-1 system (28).
Fas-based killing was first reported to be active in the absence
Fig. 6. MLC-stimulated T lymphocytes contain an intracellular pool
of FasL Sorted MLC-denved T lymphocytes were analyzed using
confocal microscopy. Permeabilized cells were labeled with the
affinity-purified antibody anti-PE62 either in the absence (A) or the
presence (B) of the specific peptide PE82 (100 ng/ml) (C) shows
labeling with an isotype control.
of calcium (11), and, previously, EGTA has been used to
discriminate perforin- and Fas-based pathways in CTL (11,29)
In particular, unspecific killing induced by CTL clones or
hybridoma cell lines clearly displayed Ca2+-independent
cytotoxic activity (30). However, recent studies of perforin-
deficient T cell clones have provided controversial results
(24) In our experimental system which studies specific target
cell lysis by primary T cells, Fas-mediated killing strictly
required extracellular calcium, most probably reflecting the
TCR-dependent up-regulation of FasL on the cell surface.
Even though FasL-Fas interaction is calcium-independent
(31), the ion requirement for TCR signaling seems to dominate
the specific Fas-killing pathway. The conflicting results in
different systems may therefore be due to varying levels of
constitutive FasL surface expression on the effector cells.
FasL belongs to the same protein family as tumor necrosis
factor-a and lymphotoxin-a (14), two mediators of slow apop-
totic cell death in sensitive targets (32). However, like perforin,
FasL induces acute cytotoxicity. As demonstrated in this
study, the kinetics of the two pathways are different. Whereas
the perforin-based pathway leads to significant cell death
shortly after target cell contact, Fas-dependent cytotoxicity is
only effective after a lag-period of 2-3 h. TCR engagement
has been shown to increase surface expression of FasL (13).
Thus, the observed lag phase may reflect the need for
sufficient FasL surface expression to ensure effective killing.
Moreover, Fas-mediated cytotoxicity required continuous de
novo protein synthesis which doubtlessly also contributes to
the delayed onset of cytotoxicity. Metabolic inhibitors were
used in earlier studies to discriminate between CD4+- and
CD8+-mediated cytotoxicity (33,34). In contrast to CD8+ cells,
CD4-mediated killing was strictly dependent on an intact
metabolic machinery similar to our findings for the Fas path-
way. Indeed, Fas-mediated cytotoxicity has been recently
proposed to be the major killing pathway in CD4-restricted T
lymphocytes (12). Although protein synthesis inhibitors inter-
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fere with FasL surface expression, the question still remains
open whether the drugs directly block the production of FasL
or a presumed FasL-activating protein that is, for example,
essential for membrane translocation or FasL oligomerization
Our data show that a first allogeneic stimulation of T
lymphocytes does not lead to pronounced cell surface expres-
sion of FasL, but rather to the synthesis of an intracellular
FasL pool which is most likely recruited to the cell surface
upon TCR triggering. This is reminiscent of CD40L which,
upon B cell encounter, is rapidly translocated to the surface
of T cells from intracellular stores. Prolonged surface expres-
sion of CD40L, however, also requires de novo synthesis and
is inhibited by cycloheximide (35). The intracellular FasL store
apparently does not suffice for efficient cell death induction.
To date, the fate of FasL on the cell membrane before and
after interaction with its receptor is not known. Due to FasL's
potentially dangerous cytolytic activity, it is conceivable that
surface FasL has only a short half-life and is either endo-
cytosed and rapidly degraded or shed from the membrane.
Our results agree with such a hypothesis, since the consider-
able quantities of FasL expressed on the cell surface upon
PMA plus ionomycin activation are insufficient for efficient
target cell lysis. The dependence on de novo synthesis of
either FasL or a FasL-activating protein is also reflected by
the decreased FasL surface expression after short exposure
to cycloheximide (35). With regard to our results, it is interes-
ting to note that CD40L surface expression is also tightly
regulated. After TCR triggering, CD40L is only transiently
expressed (36) and subsequent interaction with its receptor
CD40 leads to down-modulation through receptor-mediated
endocytosis (37). A similar mechanism may also be envisaged
for FasL. Thus, FasL-Fas interaction upon effector-target
cell contact would lead to continuous elimination of FasL,
explaining the need for de novo protein synthesis. Given
the dramatic effect seen after systemic delivery of anti-Fas
antibodies to mice and the proposed role for the Fas/Apo-1
system in immune homeostasis, a tight regulation of FasL
expression and activity may indeed be premordial. Thus, it is
tempting to propose that certain pathological situations may
well result from a misfunction of such regulatory mechanisms.
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